Aromatase catalyzes the final step in the biosynthesis of estrogen and reduced endogenous estrogen levels leading to a loss of estrogen-mediated protection from endothelial dysfunction and cardiovascular disease in postmenopausal women4,5. This evidence concerns the gene CYP19A1 and endothelial dysfunction.